hD

Balance Sheet Summary

Taubman Centers (TCO) quarterly balance sheet covering the six quarters from June 2019 to September 2020, as reported to the SEC.

  • Taubman Centers had total Assets of $4.58B and total Liabilities of $4.88B as of September 30, 2020. That leaves shareholders' equity of -$297.95M.
  • Total Assets were up 0.94% from $4.54B a year earlier.
  • Cash and cash equivalents (Note 13) was $256.51M, up 309.9% from $62.57M. That is 5.6% of total assets.
  • Notes Payable were $3.9B, or 85.1% of total assets, up 7.2% from $3.63B.

A balance sheet shows what a company owns and what it owes on a single date. The difference between the two belongs to shareholders.

Figures in USD millions
Sep'20Jun'20Mar'20Dec'19Sep'19Jun'19
Assets:
Real Estate Investment Property, at Cost

4,725

4,744

4,737

4,731

4,805

4,787

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Real Estate Investment Property, at Cost

4,725

4,744

4,737

4,731

4,805

4,787

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accumulated depreciation and amortization

1,625

1,610

1,553

1,514

1,510

1,484

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accumulated depreciation and amortization

1,625

1,610

1,553

1,514

1,510

1,484

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Real Estate Investment Property, Net

3,100

3,133

3,183

3,216

3,295

3,303

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Real Estate Investment Property, Net

3,100

3,133

3,183

3,216

3,295

3,303

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Equity Method Investments

787

790

788

831

825

763

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Equity Method Investments

787

790

788

831

825

763

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Cash and cash equivalents (Note 13)

256

240

395

102

62

42

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Cash and cash equivalents (Note 13)

256

240

395

102

62

42

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Restricted Cash and Cash Equivalents

0

0

0

0

0

30

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Restricted Cash and Cash Equivalents

0

0

0

0

0

30

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accounts and notes receivable (Note 1)

172

169

90

95

84

78

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accounts and notes receivable (Note 1)

172

169

90

95

84

78

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accounts receivable from related parties

4

0

1

2

5

1

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accounts receivable from related parties

4

0

1

2

5

1

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating Lease, Right-of-Use Asset

172

172

173

173

174

175

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating Lease, Right-of-Use Asset

172

172

173

173

174

175

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Deferred charges and other assets

85

83

92

92

87

89

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Deferred charges and other assets

85

83

92

92

87

89

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Assets of centers held for sale (Note 2)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Assets of centers held for sale (Note 2)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total Assets

4,579

4,591

4,727

4,515

4,536

4,485

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total Assets

4,579

4,591

4,727

4,515

4,536

4,485

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Liabilities:
Notes Payable

3,897

3,900

4,003

3,710

3,634

3,812

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Notes Payable

3,897

3,900

4,003

3,710

3,634

3,812

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Installment notes (Notes 2 and 8)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Installment notes (Notes 2 and 8)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accounts Payable and Accrued Liabilities

278

254

252

268

269

270

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accounts Payable and Accrued Liabilities

278

254

252

268

269

270

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating lease liabilities

240

240

241

240

241

241

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Operating lease liabilities

240

240

241

240

241

241

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Distributions In Excess Of Investments In And Net Income Of Unconsolidated Joint Ventures

461

470

471

473

481

485

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Distributions In Excess Of Investments In And Net Income Of Unconsolidated Joint Ventures

461

470

471

473

481

485

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Liabilities of centers held for sale (Note 2)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Liabilities of centers held for sale (Note 2)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total Liabilities

4,877

4,866

4,968

4,692

4,625

4,809

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Total Liabilities

4,877

4,866

4,968

4,692

4,625

4,809

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Commitments and contingencies (Notes 5, 6, 7, 8, and 9)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Commitments and contingencies (Notes 5, 6, 7, 8, and 9)

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Redeemable Noncontrolling Interest, Equity, Carrying Amount [Abstract]
Redeemable Noncontrolling Interest, Equity, Carrying Amount

-

-

-

-

-

6

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Redeemable Noncontrolling Interest, Equity, Carrying Amount

-

-

-

-

-

6

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Equity (Deficit):
Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests

-

-

-

-

-

-

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Series B Non-Participating Convertible Preferred Stock, $0.001 par and liquidation value, 40,000,000 shares authorized, 25,979,064 and 26,398,473 shares issued and outstanding at September 30, 2020 and December 31, 2019

0

0

0

0

0

0

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Series B Non-Participating Convertible Preferred Stock, $0.001 par and liquidation value, 40,000,000 shares authorized, 25,979,064 and 26,398,473 shares issued and outstanding at September 30, 2020 and December 31, 2019

0

0

0

0

0

0

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Common Stock, $0.01 par value, 250,000,000 shares authorized, 61,723,103 and 61,228,579 shares issued and outstanding at September 30, 2020 and December 31, 2019

0

0

0

0

0

0

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Common Stock, $0.01 par value, 250,000,000 shares authorized, 61,723,103 and 61,228,579 shares issued and outstanding at September 30, 2020 and December 31, 2019

0

0

0

0

0

0

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Additional paid-in capital

746

745

742

741

740

739

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Additional paid-in capital

746

745

742

741

740

739

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accumulated Other Comprehensive Income (Loss), Net of Tax

-41

-54

-61

-39

-46

-44

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Accumulated Other Comprehensive Income (Loss), Net of Tax

-41

-54

-61

-39

-46

-44

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Dividends in excess of net income (Note 7)

802

772

738

712

637

802

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Dividends in excess of net income (Note 7)

802

772

738

712

637

802

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Stockholders' Equity Attributable to Parent

-96

-81

-56

-10

56

-107

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Stockholders' Equity Attributable to Parent

-96

-81

-56

-10

56

-107

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Noncontrolling interests (Note 6)

-201

-193

-184

-167

-145

-222

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Noncontrolling interests (Note 6)

-201

-193

-184

-167

-145

-222

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest

-297

-274

-241

-177

-88

-329

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest

-297

-274

-241

-177

-88

-329

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Liabilities and Equity

4,579

4,591

4,727

4,515

4,536

4,485

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

Liabilities and Equity

4,579

4,591

4,727

4,515

4,536

4,485

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx

xxxxx